Annual report pursuant to Section 13 and 15(d)

Note 11 - Segment Information (Details Textual)

v3.7.0.1
Note 11 - Segment Information (Details Textual)
12 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2015
Number of Reportable Segments 3    
Biotechnology [Member] | Sales Revenue, Segment [Member] | Customer Concentration Risk [Member]      
Number of Major Customers 0 0 0
Protein Platforms [Member] | Sales Revenue, Segment [Member] | Customer Concentration Risk [Member]      
Number of Major Customers 0 0  
Diagnostics [Member] | Sales Revenue, Segment [Member] | Customer Concentration Risk [Member]      
Number of Major Customers 1 0 1
Diagnostics [Member] | Sales Revenue, Segment [Member] | Customer Concentration Risk [Member] | One Customer [Member]      
Concentration Risk, Percentage 12.00%   13.00%